Onse INDO CFB SERPING1 SP110 PSMB9 NCF1C TAP2 Gene annotation Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse), mRNA Interferon-induced protein with tetratricopeptide repeats 1, transcript variant 2, mRNA Interferon-induced protein with tetratricopeptide repeats three, mRNA Interferon-stimulated gene, 15 kDa, mRNA Interferon-stimulated exonuclease gene, 20 kDa, mRNA 2=-5=-oligoadenylate synthetase two, 69/71 kDa, transcript variant 1, mRNA Interferon-induced protein with tetratricopeptide repeats 2, mRNA Myxovirus (influenza virus) resistance two (mouse), mRNA Radical S-adenosyl methionine domain containing 2, Cig5, viperin mRNA 2=-5=-oligoadenylate synthetase-like, transcript variant 2, mRNA Interferon regulatory issue 7, transcript variant b, mRNA Signal transducer and activator of transcription 1, 91 kDa, transcript variant alpha, mRNA 2=-5=-oligoadenylate synthetase three, one hundred kDa, mRNA 2=,5=-oligoadenylate synthetase 1, 40/46 kDa, transcript variant 2, mRNA Interferon-induced protein 35, mRNA Interferon induced with helicase C domain 1, MDA5 mRNA Indoleamine-pyrrole 2,three dioxygenase, mRNA Complement factor B, mRNA Serpin peptidase inhibitor, clade G (C1 inhibitor), member 1, transcript variant two, mRNA SP110 nuclear body protein, transcript variant b, mRNA Proteasome (prosome, macropain) subunit, beta sort, 9 (big multifunctional peptidase 2), transcript variant 1, mRNA Neutrophil cytosolic factor 1C pseudogene, non-coding RNA Transporter 2, ATP-binding cassette, sub-family B (MDR/TAP), transcript variant 2, mRNA Chemokine (C-C motif) ligand 8, mRNA Chemokine (C-X-C motif) ligand ten, mRNA Chemokine (C-C motif) ligand 7, mRNA Chemokine (C-C motif) ligand 13, mRNA Chemokine (C-C motif) ligand 19, mRNA Tumor necrosis factor (ligand) superfamily, member ten, TRAIL mRNA Chemokine (C-C motif) ligand 5, mRNA Interleukin 18-binding protein, transcript variant A, mRNA CD48 molecule, mRNA Fold improve 55 39 34 32 28 27 25 24 22 16 15 14 13 10 9 7 30 22 18 6 five four 3 Function GTPase RNA binding RNA binding Ubiquitin-like modifier RNase RNA synthetase RNA binding GTPase Lipid synthesis RNA synthetase Transcription factor Transcription element RNA synthetase RNA synthetase Transcription issue RNA helicase Amino acid degradation Protease Protease inhibitor Transcription issue Protease ROI production Peptide transporterInflammatory responseCCL8 CXCL10 CCL7 CCL13 CCL19 TNFSF10 CCL5 IL18BP CD111 41 9 9 9 9 6 4Leukocyte trafficking Leukocyte trafficking Leukocyte trafficking Leukocyte trafficking Leukocyte trafficking Apoptosis Leukocyte trafficking Immunosuppression Lymphocyte activationCig5, cytomegalovirus-inducible gene 5; MDA5, melanoma differentiation-associated protein 5; PKR, protein kinase, RNA related; ROI, radical oxygen intermediate; TRAIL, TNF-related apoptosis-inducing ligand; viperin, virus inhibitory protein, endoplasmic reticulum connected, interferon inducible.Propidium DNA/RNA Synthesis Latent HCMV infection alters the potential of monocytes to respond to innate immune triggers.Pyrogallol Protocol Trafficking of monocytes in the peripheral blood to websites of infection is crucial for manage and clearance of pathogens.PMID:23381601 Following recruitment, monocytes function to promote immune defense by inducing production of variety I interferon and proinflammatory cytokines (65). To identify if latently infected monocytes can mount responses against identified triggers of innate immunity, cells that had been either mock infected or TB40/E infected had been challenged with Newc.